Neurocrine Biosciences Announces R&D Strategy Focused on Advancing Novel Therapies in Neuroscience and Endocrinology, Expanding CRF Platform for Metabolic Diseases, and Targeting Multiple New Medicine Approvals by Decade’s End

Reuters · 1d ago

Please log in to view news